REGENERON PHARMACEUTICALS, INC. Net Change in Cash 2008-2026 | REGN
What is net change in cash?
Net change in cash represents the total increase or decrease in cash and cash equivalents during the reporting period.
What is REGENERON PHARMACEUTICALS, INC.'s current net change in cash?
REGENERON PHARMACEUTICALS, INC. (REGN) annual net change in cash for 2025 was $634.7M, a 355.10% increase from 2024. REGENERON PHARMACEUTICALS, INC. net change in cash for the quarter ending March 31, 2026 was $-153.1M.
What was REGENERON PHARMACEUTICALS, INC.'s net change in cash in 2024?
REGENERON PHARMACEUTICALS, INC. annual net change in cash for 2024 was $-248.8M, a 34.80% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s net change in cash in 2023?
REGENERON PHARMACEUTICALS, INC. annual net change in cash for 2023 was $-381.6M, a 272.44% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year net change in cash CAGR?
REGENERON PHARMACEUTICALS, INC. net change in cash grew at a compound annual growth rate (CAGR) of 1.92% from FY2020 to FY2025, going from $577.0M to $634.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $634.7M | +355.1% | 10-K |
| FY2024 | $-248.8M | +34.8% | 10-K |
| FY2023 | $-381.6M | -272.4% | 10-K |
| FY2022 | $221.3M | -68.0% | 10-K |
| FY2021 | $690.8M | +19.7% | 10-K |
| FY2020 | $577.0M | +284.4% | 10-K |
| FY2019 | $150.1M | -77.1% | 10-K |
| FY2018 | $655.0M | +136.0% | 10-K |
| FY2017 | $277.5M | +206.2% | 10-K |
| FY2016 | $-261.4M | -263.0% | 10-K |
| FY2015 | $160.4M | +41.8% | 10-K |
| FY2014 | $113.1M | -63.0% | 10-K |
| FY2013 | $305.3M | +220.5% | 10-K |
| FY2012 | $-253.3M | -168.3% | 10-K |
| FY2011 | $371.0M | +492.6% | 10-K |
| FY2010 | $-94.5M | -132.1% | 10-K |
| FY2009 | $-40.7M | +83.8% | 10-K |
| FY2008 | $-251.1M | - | 10-K |